Jeremy Kasdin
Remy Blaire sits down with John Yu, CEO and Chairman of Kairos Pharmaceutics, to discuss how the company is developing groundbreaking therapeutics aimed at reversing cancer drug resistance. Yu explains the science behind Kairos’s innovative approach, the potential impact on cancer treatment, and how these advancements could improve patient outcomes.
How Kairos is innovating cancer treatment by targeting cancer drug resistance with John Yu
Host
